Influenza in patients with cancer after 2009 pandemic AH1N1: An 8‐year follow‐up study in Mexico
Open Access
- 20 November 2019
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 14 (2), 196-203
- https://doi.org/10.1111/irv.12704
Abstract
Background Immunosupressed patients are at high risk of influenza‐related complications. Influenza AH1N1 has been hypothesized to induce worse outcomes in patients with malignancies, but after the A(H1N1)pdm09 few publications have analyzed the presentation and complications related to influenza afterward. Objectives We aimed to describe the characteristics, risk factors, and outcomes of influenza in an oncologic center after the 2009 pandemic and to compare our case distribution to the National community acquired influenza databases in Mexico and the United States. Methods We reviewed the cases of confirmed influenza in patients with cancer from an oncological center in Mexico from April 2009 to April 2017. Data on severity and influenza type, malignancy, comorbidities, and outcomes were recorded. We correlated data between the Centers for Disease Control and Prevention (CDC) in the United States and SISVEFLU (Influenza Surveillance Program) in Mexico. Results One hundred eighty‐eight patients were included; 75 (39.9%) had a solid neoplasm and 113 (60.1%) had hematologic malignancies. AH1N1 was the most frequent influenza type (54.2%). Patients with hematologic malignancies had more pneumonia (55% vs 25%, P < .001), needed more hospitalizations (75% vs 39% P < .001), had higher all‐cause mortality at 30 days (20% vs 9% P = .048) and influenza‐associated mortality (17% vs 7% P = .041). Thirty (16%) patients died within 30 days, and 24 (12.7%) were related to influenza. Influenza type was not associated with worse outcomes. Yearly occurrence of influenza reported by the CDC and SISVEFLU showed a significant correlation (ρ = 0.823, P = .006). Conclusions AH1N1 was the dominant serotype. Patients with hematologic malignancies had more severe influenza and presented worse outcomes. Annual SISVEFLU and CDC surveillance information showed a similar distribution of cases along time but influenza serotypes did not match for all seasons.Keywords
This publication has 21 references indexed in Scilit:
- Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centersJournal of Medical Virology, 2017
- [Behavior of influenza seasons in Mexico from 2010 to 2016: Analysis and prospective].2017
- Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study.F1000Research, 2014
- Clinical presentations and outcomes of influenza infection among hematology/oncology patients from a single cancer center: pandemic and post-pandemic seasonsScandinavian Journal of Infectious Diseases, 2014
- Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort studyLeukemia & Lymphoma, 2012
- Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipientsBlood, 2011
- Risk factors for pneumonia in immunocompromised patients with influenzaRespiratory Medicine, 2010
- 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipientsJournal of Infection, 2010
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesThe Lancet Infectious Diseases, 2009
- Epidemiology and outcomes of hospitalization of influenza in the cancer population in TaiwanZeitschrift für Krebsforschung und Klinische Onkologie, 2009